
<DOC>
<DOCNO>WT01-B03-192</DOCNO>
<DOCOLDNO>IA046-000815-B032-193</DOCOLDNO>
<DOCHDR>
http://www.gothic.net:80/people/5_1.htm 205.178.27.23 19970119002638 text/html 16814
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sun, 19 Jan 1997 00:29:50 GMT
Content-Type: text/html
Accept-Ranges: bytes
Last-Modified: Sat, 07 Dec 1996 01:46:05 GMT
Content-Length: 16615
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>The Supergen Team</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body bgcolor="#FFFFFF">

<table border="0" width="550">
    <tr>
        <td><!--webbot bot="ImageMap"
        rectangle=" (396,1) (440, 12)  5_0.htm"
        polygon=" (344,11) (374,2) (391,16) (394,30) (371,37) (368,61) (349,59) (341,33) (344,11) 5_0.htm"
        rectangle=" (435,54) (495, 65)  ../product/2_0.htm"
        polygon=" (406,27) (424,46) (428,72) (407,94) (386,90) (385,84) (369,66) (369,61) (371,38) (406,27) ../product/2_0.htm"
        rectangle=" (393,114) (525, 124)  ../patent/4_0.htm"
        polygon=" (330,75) (366,64) (384,86) (390,110) (366,134) (334,126) (325,103) (330,75) ../patent/4_0.htm"
        rectangle=" (205,75) (271, 96)  ../invest/6_0.htm"
        polygon=" (313,56) (329,74) (324,102) (327,110) (313,123) (286,117) (273,91) (279,65) (313,56) ../invest/6_0.htm"
        rectangle=" (196,30) (282, 41)  ../perform/3_0.htm"
        polygon=" (291,28) (323,16) (338,34) (345,58) (330,72) (313,54) (290,61) (286,49) (291,28) ../perform/3_0.htm"
        rectangle=" (8,2) (105, 25)  ../index.htm"
        rectangle=" (9,46) (81, 61)  ../contact.htm"
        rectangle=" (10,62) (80, 77)  ../search.htm"
        rectangle=" (10,78) (79, 93)  ../map.htm"
        src="../images/newnav.gif" border="0" width="528"
        height="136" startspan --><MAP NAME="FrontPageMap"><AREA SHAPE="RECT" COORDS="396, 1, 440, 12" HREF="5_0.htm"><AREA SHAPE="POLYGON" COORDS="344, 11, 374, 2, 391, 16, 394, 30, 371, 37, 368, 61, 349, 59, 341, 33, 344, 11" HREF="5_0.htm"><AREA SHAPE="RECT" COORDS="435, 54, 495, 65" HREF="../product/2_0.htm"><AREA SHAPE="POLYGON" COORDS="406, 27, 424, 46, 428, 72, 407, 94, 386, 90, 385, 84, 369, 66, 369, 61, 371, 38, 406, 27" HREF="../product/2_0.htm"><AREA SHAPE="RECT" COORDS="393, 114, 525, 124" HREF="../patent/4_0.htm"><AREA SHAPE="POLYGON" COORDS="330, 75, 366, 64, 384, 86, 390, 110, 366, 134, 334, 126, 325, 103, 330, 75" HREF="../patent/4_0.htm"><AREA SHAPE="RECT" COORDS="205, 75, 271, 96" HREF="../invest/6_0.htm"><AREA SHAPE="POLYGON" COORDS="313, 56, 329, 74, 324, 102, 327, 110, 313, 123, 286, 117, 273, 91, 279, 65, 313, 56" HREF="../invest/6_0.htm"><AREA SHAPE="RECT" COORDS="196, 30, 282, 41" HREF="../perform/3_0.htm"><AREA SHAPE="POLYGON" COORDS="291, 28, 323, 16, 338, 34, 345, 58, 330, 72, 313, 54, 290, 61, 286, 49, 291, 28" HREF="../perform/3_0.htm"><AREA SHAPE="RECT" COORDS="8, 2, 105, 25" HREF="../index.htm"><AREA SHAPE="RECT" COORDS="9, 46, 81, 61" HREF="../contact.htm"><AREA SHAPE="RECT" COORDS="10, 62, 80, 77" HREF="../search.htm"><AREA SHAPE="RECT" COORDS="10, 78, 79, 93" HREF="../map.htm"></MAP><a
        href="../_vti_bin/shtml.dll/people/5_1.htm/map"><img
        src="../images/newnav.gif" width="528" ismap
        usemap="#FrontPageMap" height="136" border="0"></a><!--webbot
        bot="ImageMap" endspan i-checksum="18178" --> </td>
    </tr>
    <tr>
        <td><!--webbot bot="ImageMap"
        rectangle=" (235,61) (300, 74)  5_0.htm"
        src="images/5_1.gif" border="0" width="305" height="109"
        startspan --><MAP NAME="FrontPageMap1"><AREA SHAPE="RECT" COORDS="235, 61, 300, 74" HREF="5_0.htm"></MAP><a
        href="../_vti_bin/shtml.dll/people/5_1.htm/map1"><img
        src="images/5_1.gif" width="305" ismap
        usemap="#FrontPageMap1" height="109" border="0"></a><!--webbot
        bot="ImageMap" endspan i-checksum="40536" --> </td>
    </tr>
</table>

<table border="0" width="550">
    <tr>
        <td><blockquote>
            <p><font color="#DE2133" size="4"><b><i>Rajesh
            Shrotriya, M.D., </i></b></font><font size="4">joined
            the company as Senior Vice President in November,
            1996. In this position, Dr. Shrotriya provides
            direction for SuperGen&#146;s scientific planning and
            operations. Prior to joining SuperGen, Dr. Shrotriya
            was Vice President and Chief Medical Officer of MGI
            Pharma, Inc. Previously he spent 18 years at
            Bristol-Myers Squibb Company, most recently as
            Executive Director, Worldwide CNS Clinical Research.
            He also served as medical Advisor to Hoechst
            Pharmaceuticals, and as an attending physician and
            member of the faculty at St. Joseph Hospital in
            Stamford, CT. In addition to his M.D., he received a
            certificate for Advanced Biomedical Research
            Management from Harvard University.</font></p>
            <p><font color="#DE2133" size="4"><b><i>Francis H.
            Lee, Ph.D.,</i></b><b> </b></font><font size="4">has
            served as Vice President of Clinical Development and
            Registrations since February 1994. Dr. Lee was a
            consultant to the Company in the capacity of director
            of clinical development and registrations from
            January 1993 to January 1994. Prior to joining the
            Company, Dr. Lee worked at the Clinical Research and
            Development Department of Fujisawa Pharmaceutical
            Company, Ltd. from 1988 to 1992, where he was
            Director of Clinical Research and Development. From
            1987 to 1988, Dr. Lee served as Director of the
            Clinical Oncology group at Warner-Lambert Company.
            From 1983 to 1987, he served as Associate Medical
            Director of Oncology and Infectious Diseases at
            DuPont Corporation. Dr. Lee received his B.A. in
            chemistry from the University of Oregon, and his
            Ph.D. in biopharmaceuticals and clinical pharmacology
            from the State University of New York in Buffalo.</font>
            </p>
            <p><font color="#DE2133" size="4"><b><i>Frank Brenner</i></b><b>
            </b></font><font size="4">joined the Company as Vice
            President of Sales and Marketing in January 1994.
            Prior to joining the Company, he was an independent
            management consultant for various biotechnology and
            pharmaceutical companies from September 1991 to
            January 1994. From December 1987 to September 1991
            Mr. Brenner was Senior Director of National Sales for
            Cetus Corporation and was a Regional Sales Manager
            from October 1986 to December 1987. Prior to that
            time, he served in a variety of positions at Lederle
            International, including as Senior Product Manager.
            Mr. Brenner received his B.S. from California State
            University.</font> </p>
            <p><font color="#DE2133" size="4"><b><i>Hank Settle</i></b></font><font
            color="#AF0000" size="4"><b><i> </i></b></font><font
            color="#000000" size="4">joined SuperGen in May 1996
            as Chief Financial Officer. From 1992 to 1995, Mr.
            Settle was a partner in Ernst &amp; Young's High
            Technology practice in Palo Alto. Prior to that, he
            was a partner in the firm's Tokyo office for five
            years, and also was a member of its International
            Mergers and Acquisition Network. He began his career
            in 1974 in Ernst &amp; Young's San Diego office,
            where he headed the group specializing in emerging
            businesses. Mr. Settle received his MBA in Finance
            from the University of California, Los Angeles.</font></p>
            <p><font color="#DE2133" size="4"><b><i>Frederick L.
            G</i></b></font><font color="#C03437" size="4"><b><i>rab,
            Ph.D.</i></b></font><font color="#C03437"><b><i> </i></b></font><font
            size="4">joined SuperGen as Vice President of
            Manufacturing in July, 1996. Before joining the
            Company, he was at Pharmacia Inc./Adria Laboratories
            from 1982 to 1996; most recently as Director of
            Regulatory Affairs. From 1971 to 1982, Dr. Grab was
            at Bristol Myers Company International Division in
            several pharmaceutical development positions, finally
            as Assistant Director. Prior to that he worked in
            pharmaceutical development at Wyeth Laboratories from
            1968 to 1971. He received his Ph.D. in Pharmaceutical
            Chemistry from the University of California, San
            Francisco Medical Center, and his B.S. in Pharmacy
            from Columbia University College of Pharmacy in New
            York.</font> </p>
            <p><font color="#DE2133" size="4"><b><i>R. David
            Lauper, Pharm. D.,</i></b></font><font size="4"> has
            served as Vice President of Oncology Product
            Development since August 1995. Dr. Lauper joined
            SuperGen from Chiron where he served as Director of
            Professional Services, Chiron Therapeutics from 1994
            to 1995. Prior to that time, from 1986 to 1993, Dr.
            Lauper served in the same capacity at Cetus
            Corporation. From 1980 to 1986, Dr. Lauper was with
            Bristol-Myers as Assistant Director of Medical
            Information Oncology. He received his Pharm.D. in
            pharmacy from the University of California School of
            Pharmacy.</font> </p>
            <p><font color="#DE2133" size="4"><b><i>Simeon M.
            Wrenn, Ph.D.,</i></b><b> </b></font><font size="4">joined
            SuperGen in January 1996 as Vice President of
            Biotechnology. From September 1995 to January 1996 he
            was a consultant to The Purdue Frederick Company, a
            privately held manufacturer and distributor of drug
            products. From 1983 to 1995, Dr. Wrenn served in
            several senior research and product development
            positions at Lederle Laboratories. He also was a
            founding scientist of Centocor, Inc. Dr. Wrenn has
            been an Assistant Professor of Medicine at Baylor
            College and the University of Pennsylvania and an
            Associate Professor of Medicine at Johns Hopkins
            University. He received his Ph.D. from Emory
            University in Atlanta, Georgia and completed his
            Postdoctoral Fellowship at Harvard Medical School and
            Massachusetts General Hospital in Boston,
            Massachusetts.</font> </p>
            <p><font color="#DE2133" size="4"><b><i>David M.
            Fineman </i></b></font><font size="4">has been a
            director of the Company since its inception. Mr.
            Fineman is a co-founder of the Company who also has
            served as Acting Chief Financial Officer and
            Secretary. He served as a General Partner of
            Strategic Pharmaceutical Partners I &amp; II, the
            California limited partnerships which provided the
            initial funding for the Company. He is a founder and
            Director of Expression Systems, Inc. He received his
            B.A. from the University of Maryland and an M.A. from
            the Graduate Faculty of the New School for Social
            Research in New York, where he also completed his
            Ph.D. course work.</font> </p>
            <p><font color="#DE2133" size="4"><b><i>J. Gregory
            Swendsen,</i></b></font><font size="4"> a co-founder
            of the Company, has served as a director of the
            Company since its inception. Mr. Swendsen was the
            Treasurer of the Company from its inception until
            December 1995. He is President of Swendsen &amp;
            Company, a management company founded in 1984 that
            specializes in venture capital in applied technology
            industries. Mr. Swendsen was a General Partner of
            Strategic Pharmaceutical Partners I &amp; II, which
            provided the initial funding for the Company. He is a
            founder and Director of Expression Systems, Inc.</font>
            </p>
            <p><font color="#DE2133" size="4"><b><i>Denis Burger,
            Ph.D.,</i></b></font><font size="4"> has served as a
            director of the Company since January 1996. Dr.
            Burger has served as President and Chief Operating
            Officer of AntiVirals Inc., a biotechnology company
            specializing in gene-targeted therapeutic and
            diagnostic products since February 1992. Dr. Burger
            was a co-founder of Epitope, Inc., a biotechnology
            company, and served as its Chairman from 1981 until
            1990. He has also been the general partner of
            Sovereign Ventures, LLC, a biotechnology consulting
            and merchant banking venture since 1991. Dr. Burger
            is a member of the Board of Directors of Cellegy
            Pharmaceuticals, Inc., Cell Robotics International,
            AntiVirals Inc., Trinity Biotech, PLC. and AcryMed,
            Inc. He received his B.A. in Bacteriology and
            Immunology from the University of California,
            Berkeley and his M.S. and Ph.D. in Microbiology and
            Immunology from the University of Arizona, Tucson.</font>
            </p>
            <p><font color="#DE2133" size="4"><b><i>Julius A.
            Vida, Ph.D.,</i></b></font><font size="4"> has served
            as a director of the Company since January 1996.
            Since June 1993, Dr. Vida has served as President of
            Vida International Pharmaceutical Consultants. From
            1976 to May 1993, Dr. Vida worked at Bristol-Myers
            Squibb, where he served as Vice President of Business
            Development, Licensing and Strategic Planning from
            1991 to 1993, as Vice President of Licensing from
            1985 to 1991 and as Director of Licensing from 1982
            to 1985. Dr. Vida is a member of the Board of
            Directors of Biomatrix, Inc., Innovir Laboratories,
            Inc., Medarex, Inc. and FibroGen, Inc., all
            biotechnology companies. Dr. Vida received his Ph.D.
            in Chemistry from Carnegie Mellon University and his
            M.B.A. from Columbia University.</font> </p>
            <p><font color="#DE2133" size="4"><b><i>Daniel Zurr,
            Ph.D.,</i></b></font><font size="4"> has been a
            director of the Company since January 1994. Dr. Zurr
            currently serves as Chief Executive Officer of
            Expression Systems, Inc. Dr. Zurr served as
            Scientific Director and Business Development Director
            of the Pharmaceutical Division of ICL from 1984 to
            1995. He also served as Director of Licensing at G.D.
            Searle &amp; Company, Limited, from 1980 to 1983. He
            was Chief Executive Officer of Plantex-Ikapharm, an
            Israeli pharmaceutical company, from 1975 to 1980.
            Dr. Zurr received his M.Sc. at the Hebrew University
            of Jerusalem and his Ph.D. from the Imperial College
            University of London in 1972.</font></p>
        </blockquote>
        </td>
    </tr>
    <tr>
        <td>&nbsp; </td>
    </tr>
</table>

<p><!--webbot bot="ImageMap"
rectangle=" (67,10) (111, 19)  5_0.htm"
rectangle=" (128,11) (186, 19)  ../product/2_0.htm"
rectangle=" (204,11) (336, 19)  ../patent/4_0.htm"
rectangle=" (353,11) (403, 19)  ../invest/6_0.htm"
rectangle=" (420,11) (504, 19)  ../perform/3_0.htm"
src="../images/lowNAV.gif" border="0" width="530" height="31"
startspan --><MAP NAME="FrontPageMap2"><AREA SHAPE="RECT" COORDS="67, 10, 111, 19" HREF="5_0.htm"><AREA SHAPE="RECT" COORDS="128, 11, 186, 19" HREF="../product/2_0.htm"><AREA SHAPE="RECT" COORDS="204, 11, 336, 19" HREF="../patent/4_0.htm"><AREA SHAPE="RECT" COORDS="353, 11, 403, 19" HREF="../invest/6_0.htm"><AREA SHAPE="RECT" COORDS="420, 11, 504, 19" HREF="../perform/3_0.htm"></MAP><a href="../_vti_bin/shtml.dll/people/5_1.htm/map2"><img
src="../images/lowNAV.gif" width="530" ismap
usemap="#FrontPageMap2" height="31" border="0"></a><!--webbot
bot="ImageMap" endspan i-checksum="45878" --> </p>
</body>
</html>
</DOC>